2020 articles

Houssari M, Dumesnil A, Tardif V, Kivelä R, Pizzinat N, Boukhalfa I, Godefroy D, Schapman D, Hemanthakumar KA, Bizou M, Henry JP, Renet S, Riou G, Rondeaux J, Anouar Y, Adriouch S, Fraineau S, Alitalo K, Richard V, Mulder P, Brakenhielm E Lymphatic and immune cell cross-talk in the heart regulates cardiac recovery after experimental myocardial infarction FASEB J 2020 ;40(7):1722-1737. https://doi.org/10.1161/ATVBAHA.120.314370

Cuijpers I, Carai P, Mendes-Ferreira P, Simmonds S, Mulder P, Miranda-Silva D, de Giorgio D, Pokreisz P, Heymans S, Jones EA The effect of different anaesthetics on echocardiographic evaluation of diastolic dysfunction in a heart failure with preserved ejection fraction model. Sci Rep 2020 Sep 24;10(1):15701. http://doi.org/10.1038/s41598-020-72924-5

Liapi, E, van Bilsen, M, Verjans, R Schroen, B tRNAs and tRNA fragments as modulators of cardiac and skeletal muscle function Biochim Biophys Acta-Molecular Cell Research  2020; 1867, 118465 doi: 10.1016/j.bbamcr.2019.03.012 https://pubmed.ncbi.nlm.nih.gov/30943428/

Summer G, Kuhn AR, Munts C, Miranda-Silva D, Leite-Moreira AF, Lourenço AP, Heymans S, Falcão-Pires I, Van Bilsen M A directed network analysis of the cardiome identifies molecular pathways contributing to the development of HFpEF  J Mol Cell Cardiol 2020: 144; 66-75 doi: 10.1016/j.yjmcc.2020.05.008  https://pubmed.ncbi.nlm.nih.gov/32422321/

Verjans, R, van Bilsen, M, Schroen, B Reviewing the Limitations of Adult Mammalian Cardiac Regeneration: Noncoding RNAs as Regulators of Cardiomyogenesis (review) Biomolecules 2020: 10, 262 doi: 10.3390/biom10020262 https://pubmed.ncbi.nlm.nih.gov/32050588/

Eiros R, Romero-González G, Gavira JJ, Beloqui O, Colina I, Landecho MF, López B, González A, Díez J, Ravassa S. Does chronic kidney disease facilitate malignant myocardial fibrosis in heart failure with preserved ejection fraction of hypertensive origin? J Clin Med 2020;9(2):pii: E404 https://pubmed.ncbi.nlm.nih.gov/32028612/   

Reviews

Cuijpers I, Simmonds SJ, van Bilsen M, Czarnowska E, González Miqueo A, Heymans S, Kuhn AR, Mulder P, Ratajska A, Jones EAV, Brakenhielm E. Microvascular and lymphatic dysfunction in HFpEF and its associated comorbidities. (review) Basic Res Cardiol. 2020;115(4):39 https://pubmed.ncbi.nlm.nih.gov/32451732/  

Brakenhielm E, González A, Díez J. Role of Cardiac Lymphatics in Myocardial Edema and Fibrosis (review) J Am Coll Cardiol. 2020;76(6):735-744 https://pubmed.ncbi.nlm.nih.gov/32762908/

Jankowska-Steifer E, Ratajska A, Czarnowska E, Badurek I, Matryba P, Niderla-Bielińska J, Ciszek B, Brakenhielm E. Assessing functional status of cardiac lymphatics: From macroscopic imaging to molecular profiling. (review) Trends Cardiovasc Med. 2020:S1050-1738(20)30085-2  https://pubmed.ncbi.nlm.nih.gov/32592746/

Ravassa S, González A, Bayés-Genís A, Lupón J, Díez J. Myocardial interstitial fibrosis in the era of precision medicine. Biomarker-based phenotyping for a personalized treatment.  (review) Rev Esp Cardiol 2020;73(3):248-254. https://pubmed.ncbi.nlm.nih.gov/31759935/

Díez J, González A, Kovacic J. Myocardial interstitial fibrosis in nonischemic heart disease, Part ¾. JACC focus seminar.  (review) J Am Coll Cardiol 2020;75:2204-2218 https://pubmed.ncbi.nlm.nih.gov/32354386/   

Romero-González G, González A, López B, Ravassa S, Díez J. Heart failure in chronic kidney disease. The emerging role of myocardial fibrosis.  (review) Nephrol Dial Transplant. 2020 in press;  doi: 10.1093/ndt/gfaa284   https://pubmed.ncbi.nlm.nih.gov/33313766/  

Simmonds SJ, Cuijpers I, Heymans S, Jones EAV. Cellular and Molecular Differences between HFpEF and HFrEF: A Step Ahead in an Improved Pathological Understanding. (review) Cells. 2020 ;9(1):242. http://doi.org/10.3390/cells9010242  

LYMIT-DIS

Targeted Lymphatic and Microvessel Treatments in metabolic-DISease HFpEF

Réalisation Internet Bordeaux LOGO internet bordeaux mini

Contact Us

Legal mentions